History of chronic lymphocytic leukemia -- Molecular biology of chronic lymphocytic leukemia -- Chronic lymphocytic leukemia: epidemiological, familial, and genetic aspects -- The origin and nature of the chronic lymphocytic leukemia lymphocyte -- Immunoglobulin variable region gene charcteristics and surface membrane phenotype define B-CLL subgroups with distrinct clinical courses -- Apoptois dysregulatin in chronic lymphocytic leukemia -- Cytokines and regulatory molecules in the patogenesis and clinical course of B-cell chronic lymphocytic leukemia -- Randomized trials: what do they teach us about chronic lymphocytic leukemia treatment? -- Genetic approaches to the therapy of chronic lymphocytic leukemia -- Combination strategies for purine nucleoside analogs -- Differential diagnosis of the chronic [beta]-cell lymphoid leukemias -- Prognostic factors in chronic lymphocytic leukemia -- Initial approach to the patient with chronic lymphocytic leukemia -- Management of the patient with relapsed or refractory chronic lymphocytic leukemia -- The use of therapeutic monoclonal antibiodies in chronic lymphocytic leukemia -- Genomic aberrations in [beta]-cell chronic lymphocytic leukemia -- Developing risk-adapted treatment strategies for chronic lymphocytic leukemia -- High-dose therapy and stem cell support n chronic lymphocytic leukemia -- Finding new therapies for patients with chronic lymphocytic leukemia -- Autoimmune disease and its management in chronic lymphocytic leukemia -- Richter's syndrome -- Supportive care in chronic lymphocytic leukemia -- Infections in patients with chronic lymphocytic leukemia: pathogenesis, sprectrum, and therapeuitc approaches -- Prolymphocytic leukemia of [beta]- and T-cell types: biology and therapy -- Chronic T-cell and NK-cell leukemias -- Current concepts in the management of hairy cell leukemia -- Psychological aspects of chronic lymphoid leukemia.